Beta-Mannosidose · Lysosomal storage disease beta-mannosidosis · β-mannosidosis · B-mannosidosis
Beta-mannosidosis is a severe, inherited metabolic disorder where a deficiency in the enzyme beta-mannosidase prevents the body from breaking down complex sugar molecules. These sugars build up inside cells, particularly damaging the central nervous system, which includes the brain and spinal cord. This cellular accumulation leads to progressive and irreversible neurological damage.
Symptoms typically appear within the first few weeks of life. Owners will notice severe neurological signs, including uncontrollable body tremors, a lack of coordination, deafness, and profound weakness.
There is no cure for this fatal condition, and veterinary care is limited to supportive care and humane euthanasia. The associated costs for diagnosis and end-of-life care typically range from 250 to 1000 EUR.
More conditions affecting the Head / nervous system.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.